This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Cramer: Molehills, All of Them

I still can't figure out what people initially didn't like about Starbucks, but I remember thinking that my charitable trust was getting a chance to buy this stock below $60 -- down a couple of bucks -- on a quarter that, to me, seemed just fine. Well, it was better than fine. Starbucks put out terrific numbers from China and the U.S. and the stock never looked back, embarking on a 10-point rally in pretty much a straight line. Now, that's what I call a buying opportunity.

Perhaps the best trade of all came from the highest-growth stocks when the interest-rate rally occurred. Those are the ones that you are never supposed to buy in an era when rates are skyrocketing -- and, after that move, I don't know how you can say they weren't doing just that.

You are supposed to go after the most highly valued stocks, since the rate rise signals inflation and a concomitant erosion of what you will pay for future earnings.

Yet how did the highest-growth stocks in the biotech world do? Celgene (CELG) and Gilead (GILD) have been downright unstoppable, taking out their old highs. Look, I get that when it comes to Celgene, as the company had just announced that it might soon be able to reapply for a favorable-use rule in Europe for its bedrock drug Revlimid. But Gilead? Nothing happened at all, and it's been the strongest one in the pack. Makes me want to go buy Regeneron (REGN) and Biogen (BIIB).

But you know which two have really taken off? How about the two stocks that are regarded as the most expensive large-cap stocks in the universe? I'm talking about Amazon (AMZN) and Netflix (NFLX). When I was at my old hedge fund, I used to go after those kinds of stocks when I started, betting that the multiple would shrink so fast off the higher rates that I could coin money. But once rates would stabilize, you'd be history -- and the shorts who did these trades this time are, indeed, history.

Not everything has bounced back. The stocks most definitely in the path of the interest-rate hurricane, the housing stocks, can't get any traction. Nevertheless, they were priced expensively going into the storm, and they have to give back some of their gains, because we know that higher rates do cool housing.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Our Tweets

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs